Vanda Pharmaceuticals Inc —— 资产负债表 (NASDAQ:VNDA) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 533.46 M593.79 M634.25 M648.44 M656.2 M488.95 M 负债总额 80.19 M88.86 M107.05 M103.53 M117.66 M161.76 M 权益总额 453.27 M504.93 M527.2 M544.91 M538.55 M327.19 M 负债及股东权益总额 533.46 M593.79 M634.25 M648.44 M656.2 M488.95 M 总债务 —————— 净债务 ——————

新闻

Vanda制药在公民人寿科学会议上展望战略增长

Vanda Pharmaceuticals at The Citizens Life Sciences Conference: Strategic Growth Insights

Micron and Palantir among market cap stock movers on Tuesday

Truist首次覆盖Vanda Pharmaceuticals股票,基于药物管线给予买入评级

Truist initiates Vanda Pharmaceuticals stock at buy on drug pipeline

FDA批准Vanda就Hetlioz时差适应症申请举行听证会

FDA grants Vanda hearing on Hetlioz jet lag application

FDA接受Vanda治疗罕见皮肤病药物imsidolimab的申请

Vanda Pharmaceuticals Breaks Through With FDA Approval, Decision Date For Skin Drug - Vanda Pharmaceuticals (NASDAQ:VNDA)

American Express, Oracle among market cap stock movers on Monday

H.C. Wainwright因FDA批准将Vanda Pharmaceuticals目标价上调至24美元

Vanda Pharmaceuticals stock price target raised to $24 by H.C. Wainwright on FDA approval